Iborra Marcos, Álvaro
Villanueva Martínez, Manuel
Fahandezh-Saddi Díaz, Homid
Article History
Received: 29 June 2022
Accepted: 9 September 2022
First Online: 29 September 2022
Declarations
:
: The study has been evaluated the proposal of the study promoter. Version protocol of March 7, 2022. Promoter: Dr. Iborra, Avanfi Clinic, Madrid Spain. The study arises following the legally established requirements, and its implementation is relevant. The necessary eligibility requirements are met protocol in relation to the study objectives and justified the foreseeable risks and discomforts to the subject. The needle-based gastrocnemius lengthening procedure for research and clinical practice. The scope of the planned financial compensation does not interfere with the respect for ethical principles. The ability of the researcher and her collaborators, and the facilities and resources available, as has been reported, are suitable for carrying out the study.
: The authors declare no competing interests.